Finasteride Cost in Georgia 2026: Cash Price, Insurance, and Compounded Options

What Does Finasteride Actually Cost in Georgia in 2026?

Generic finasteride costs roughly $12 per month at Georgia retail pharmacies when you pay cash, making it one of the most affordable prescription hair-loss and BPH treatments available. The Merck brand carries a list price near $85 per month, but almost no cash-pay patient needs to pay that amount in 2026.

Prices vary by pharmacy, strength, and quantity. A 30-count supply of generic finasteride 1 mg (androgenetic alopecia dosing) and 5 mg (BPH dosing) are priced similarly at most Georgia chains. The FDA approved Proscar (finasteride 5 mg) in 1992 for BPH and Propecia (finasteride 1 mg) in 1997 for male-pattern hair loss, and generic competition has driven prices down sharply since patent expiration. The FDA's current prescribing-information label for finasteride is available on the FDA accessdata portal.

Kaufman et al. demonstrated in a landmark 48-week trial (N=1,553) that finasteride 1 mg daily produced statistically significant increases in hair count versus placebo (P<0.001), establishing the clinical rationale for long-term daily use that drives ongoing patient demand. [1] Because patients typically take finasteride for years, the monthly price difference between a $12 generic and an $85 brand compounds to more than $800 per year.

GoodRx, RxSaver, and pharmacy-specific discount programs regularly bring the cash price below $15 for a 30-day supply at Kroger, CVS, Walgreens, Publix, and Walmart locations across Atlanta, Savannah, Augusta, and Macon. The NIH DailyMed entry for finasteride tablets lists the approved labeling and inactive-ingredient data relevant to patients with excipient sensitivities.

Georgia Medicaid Coverage for Finasteride

Georgia Medicaid does not cover finasteride for androgenetic alopecia or for BPH in 2026. The Georgia Department of Community Health Preferred Drug List classifies finasteride as a non-covered benefit for these two indications. Coverage is limited to specific oncology-adjacent contexts, which affects a very small subset of patients.

This is consistent with national Medicaid trends. The Centers for Medicare and Medicaid Services permit states to exclude drugs deemed cosmetic, and most state Medicaid programs follow that logic for AGA treatments. CMS guidance on Medicaid covered outpatient drugs is codified under 42 CFR Part 447.

Patients covered by Georgia Medicaid who need finasteride for BPH may have a narrow path to coverage if their prescriber documents medical necessity under a specific diagnosis code and requests a prior authorization. Approval is not guaranteed and the process can take several weeks. For most Medicaid patients, the $12 cash-pay generic price is the practical solution given that it is already low relative to most prescription costs.

Dual-eligible patients (Medicare Part D plus Medicaid) should check their Part D plan formulary separately. Many Part D plans place generic finasteride on Tier 1, meaning a $0 to $5 copay. Medicare Part D formulary requirements are described in CMS guidance published at cms.gov.

Does Private Insurance Cover Finasteride in Georgia?

Most major commercial plans available through Georgia's ACA marketplace and employer-sponsored insurance do cover generic finasteride, but tier placement and indication matter. Plans typically cover the 5 mg tablet for BPH on Tier 1 or Tier 2 without prior authorization. Coverage for the 1 mg tablet for androgenetic alopecia is less consistent because some plans code it as cosmetic.

Blue Cross Blue Shield of Georgia, Ambetter from Peach State Health Management, and UnitedHealthcare plans sold in Georgia generally list generic finasteride on their formularies for BPH. AHIP publishes annual formulary transparency data showing how generics are tiered across commercial plans.

A Tier 1 copay in Georgia typically runs $0 to $10 per 30-day fill. A Tier 2 copay runs $15 to $45 depending on the plan design. Even without insurance, the $12 cash price often beats a Tier 2 copay after deductibles reset in January, so patients should compare both routes at the pharmacy counter each calendar year.

Prior authorization for AGA use is requested by the prescriber and requires documentation of diagnosis code L64 (androgenic alopecia). Some plans deny AGA coverage categorically; others approve it after medical necessity review. The American Academy of Dermatology's clinical guidelines address finasteride prescribing for androgenetic alopecia.

Compounded Finasteride in Georgia: Legality and Pricing

Compounded finasteride is legal in Georgia when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. Georgia follows federal 503A compounding standards as established by the Drug Quality and Security Act of 2013, and the Georgia State Board of Pharmacy licenses and inspects compounding facilities in the state. FDA oversight of 503A compounding pharmacies is described at FDA.gov.

The typical price for compounded finasteride in Georgia runs about $45 per month. This is higher than the $12 generic cash price but may be chosen by patients who need a non-standard dose form, a specific excipient-free formulation, or a topical preparation. Topical finasteride (commonly 0.1% to 0.25% solution) is not FDA-approved as a finished drug product, so it is only available through compounding. Some patients prefer topical administration to reduce systemic 5-alpha-reductase inhibition.

503B outsourcing facilities, which operate under stricter FDA oversight than 503A pharmacies, may also supply compounded finasteride to Georgia medical practices. The FDA's list of registered 503B outsourcing facilities is maintained at accessdata.fda.gov.

Patients should confirm that any compounding pharmacy they use holds a current Georgia State Board of Pharmacy license and, if the pharmacy is located out of state, that it is licensed to ship into Georgia. Unlicensed internet pharmacies operating outside this framework are not legal sources. The NABP maintains a database of accredited compounding pharmacies at nabp.pharmacy.

Compounded preparations are not bioequivalence-tested against the FDA-approved product. Patients switching from branded or generic oral finasteride to a compounded formulation should discuss the change with their prescriber and monitor clinical response over a 6 to 12 month period given finasteride's slow onset. [2]

Telehealth Prescribing of Finasteride in Georgia

Georgia permits telehealth prescribing of finasteride. Prescribers licensed in Georgia may conduct an asynchronous or synchronous telehealth visit, establish a valid patient-provider relationship, and issue a finasteride prescription that can be filled at any Georgia retail or mail-order pharmacy. No in-person visit is required under current Georgia telehealth law.

Telehealth platforms operating in Georgia include national services such as Hims, Keeps, Roman, and Ro, as well as regional telehealth groups and direct-primary-care practices. Most charge $0 to $25 for the initial visit and route the prescription to the patient's preferred pharmacy or ship generic tablets directly. The Federation of State Medical Boards' telehealth policy compendium tracks state-by-state prescribing rules.

Georgia's telehealth parity law (O.C.G.A. § 33-24-56.4) requires that commercial insurers cover telehealth services at parity with in-person visits, meaning a telehealth consultation for hair loss or BPH should be billed and reimbursed under standard office-visit codes. This does not automatically guarantee coverage of the resulting finasteride prescription, but it removes one financial barrier to access. Georgia telehealth parity legislation is summarized by NCSL.

Asynchronous platforms (photo-based review) tend to cost less than synchronous video visits. Either pathway is clinically appropriate for straightforward AGA presentations in adult men who have no contraindications. Prescribers conducting telehealth visits in Georgia must still adhere to standard-of-care requirements, including reviewing contraindications such as pregnancy exposure risk and baseline PSA consideration in patients over 50. [3]

How to Get the Cheapest Finasteride Price in Georgia

Getting finasteride for $12 per month or less in Georgia requires only a few steps. First, ask for the generic (finasteride, not Propecia or Proscar by brand name) at a 30-day or 90-day supply. Second, use a free coupon from GoodRx, RxSaver, or Blink Health at the pharmacy counter regardless of whether you have insurance, since these coupons often beat the insured copay. Third, consider a 90-day supply, which frequently drops the per-pill cost further at mail-order or big-box pharmacies.

Walmart's $4/$10 generic list includes finasteride 5 mg in many Georgia stores. Publix offers free or heavily discounted generics on a rotating list that may include finasteride. The FDA's Orange Book lists all approved finasteride generic manufacturers, confirming bioequivalence to the reference listed drug.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) listed finasteride 1 mg at approximately $6 for 30 tablets as of early 2026, with shipping available to Georgia addresses. That price point is accessible without any coupon or insurance card. The NCBI bookshelf chapter on 5-alpha-reductase inhibitor pharmacology provides prescribing context.

Patients with low income may qualify for the Georgia Gateway benefits portal, which screens for multiple assistance programs. Merck's patient assistance program covers branded Propecia for patients who meet income thresholds, though the generic's low cash price makes the branded program rarely the best financial path. Merck's patient-assistance information is accessible through NeedyMeds, catalogued by NIH.

The HealthRX Georgia Finasteride Cost Decision Framework guides patients through four sequential questions: (1) Do you have commercial insurance? Check formulary tier first. (2) Is your Tier 1 copay above $12? If yes, pay cash with a coupon. (3) Do you need a non-standard dose form or topical route? If yes, consult a 503A compounding pharmacy. (4) Do you lack transportation to a pharmacy? Use telehealth plus mail-order for the full $0-visit-plus-$12-drug pathway.

Clinical Background: Why Finasteride Works and What the Evidence Shows

Finasteride inhibits Type II 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT). DHT is the principal androgen driving follicular miniaturization in genetically susceptible men. Oral finasteride 1 mg daily reduces serum DHT by approximately 65% to 70%. [4]

Kaufman et al. (J Am Acad Dermatol, 1998, N=1,553) showed that finasteride 1 mg daily over 48 weeks increased total hair count in the vertex scalp area and that 48% of treated men showed improvement in global photographic assessment versus 7% in the placebo group (P<0.001). [1] The drug's efficacy for BPH rests on a different trial base. The PLESS trial (N=3,040, 4-year follow-up) showed that finasteride 5 mg reduced prostate volume by 18%, decreased acute urinary retention risk by 57%, and reduced the need for BPH-related surgery by 55% versus placebo. [5]

The Prostate Cancer Prevention Trial (PCPT, N=18,882) found that finasteride reduced prostate cancer detection by 24.8% over 7 years compared to placebo, though a higher proportion of high-grade cancers (Gleason 7 to 10) was observed in the treatment group, a finding whose interpretation remains debated. [6] The FDA added a label update in 2011 addressing this, and prescribers should discuss the PCPT data with patients undergoing long-term finasteride use for BPH. The FDA safety communication on 5-ARI cancer risk is available at fda.gov.

Adverse effects reported in clinical trials include decreased libido (1.8% finasteride vs. 1.3% placebo in Kaufman et al.), ejaculatory disorder (1.2% vs. 0.7%), and erectile dysfunction (1.3% vs. 0.7%). [1] Post-finasteride syndrome, a reported persistence of sexual, neurological, and psychological symptoms after drug discontinuation, is the subject of ongoing investigation. The NIH has catalogued post-finasteride syndrome case series at PubMed.

Dosing, Monitoring, and Duration of Treatment in Georgia Clinical Practice

The standard AGA dose is finasteride 1 mg orally once daily. The standard BPH dose is 5 mg orally once daily. Both doses are taken without regard to food. Finasteride is pregnancy category X: it must not be handled by pregnant women in crushed or broken form due to risk of male fetal genital abnormality, and this warning appears prominently on all Georgia pharmacy dispensing labels. [7]

PSA monitoring deserves attention in Georgia clinical practice. Finasteride approximately halves serum PSA values, so a PSA drawn after 6 or more months of finasteride therapy should be doubled to estimate the true underlying PSA for prostate cancer screening purposes. The AUA guideline on PSA interpretation during 5-ARI therapy is referenced in NIH clinical literature. Georgia urologists and primary-care physicians routinely apply this 2x correction factor.

Hair-count response to finasteride is slow. Most clinical guidelines recommend a minimum 12-month trial before concluding the drug has failed, as early shedding in months 1 to 3 is common and does not predict poor outcomes. The AAD clinical practice guidelines recommend at minimum one year of treatment before efficacy assessment. Patients discontinuing finasteride can expect hair-count to return toward baseline within 9 to 12 months of stopping. [8]

Liver function monitoring is not routinely required for standard finasteride doses. Finasteride is metabolized hepatically via CYP3A4, so clinicians should be aware of interactions with strong CYP3A4 inhibitors, though clinically meaningful interactions at the 1 mg or 5 mg dose are uncommon. The NIH drug interaction database entry for finasteride notes the CYP3A4 pathway.

Georgia-Specific Pharmacy and Prescriber Resources

Georgia residents have access to finasteride through approximately 1,200 licensed retail pharmacies across the state's 159 counties. Rural Georgia counties in the Coastal Plain and Mountain regions may have fewer pharmacy options, making mail-order and telehealth-plus-mail pathways especially practical for patients more than 30 miles from the nearest chain pharmacy.

The Georgia Composite Medical Board licenses prescribers who may prescribe finasteride via telehealth. The Georgia State Board of Pharmacy licenses dispensing pharmacies and compounding facilities. Both boards maintain public license verification tools online. Georgia Board of Pharmacy licensing information aligns with NABP model pharmacy act standards described at ncbi.nlm.nih.gov.

Federally Qualified Health Centers (FQHCs) operating under HRSA in Georgia, including Grady Health System's primary care network in Atlanta and the Satilla Community Services network in Southeast Georgia, offer sliding-scale visits where finasteride can be prescribed. HRSA maintains the FQHC locator database at findahealthcenter.hrsa.gov.

The 340B Drug Pricing Program, available to qualifying FQHCs, can reduce finasteride acquisition cost to well below the retail generic price, and those savings are often passed to patients. At a 340B-participating clinic, finasteride may cost $0 to $5 per month for eligible low-income patients. 340B program requirements are governed by HRSA as described at hrsa.gov.